BEKTAŞ, Ö. Et Al. 2010. Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2 , 13-16.

BEKTAŞ, Ö., HAZNEDAROĞLU, İ. C., BÜYÜKAŞIK, Y., SAYINALP, N., AKSU, S., GÖKER, H., ... ÖZCEBE, O. İ.(2010). Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2, 13-16.

BEKTAŞ, ÖZLEN Et Al. "Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2, 13-16, 2010

BEKTAŞ, ÖZLEN Et Al. "Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2, pp.13-16, 2010

BEKTAŞ, Ö. Et Al. (2010) . "Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2, pp.13-16.

@article{article, author={ÖZLEN BEKTAŞ Et Al. }, title={Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2010, pages={13-16} }